Amanda Schwer, M.D.

Published Manuscripts

• Rabinovitch, R and Schwer, A. MammoSite brachytherapy –evolution and current status. Breast Cancer Online, October 2005.
• Schwer, A. and Gaspar, L. Update in the treatment of brain metastases from lung cancer. Clinical Lung Cancer 8(3):180-186, 2006.
• Schwer, A; Damek, D; Kavanagh, B; Gaspar, L; Lillehei, K; Stuhr, K; Chen, C. A phase I dose escalation study of hypofractionated stereotactic radiosurgery (SRS) in combination with gefitinib (ZD1839, IRESSA®) in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 70(4): 993-1001, 2008.
• Ballonoff, A; Rusthoven, K; Schwer, A; McCammon, R; Kavanagh, B; Bassetti, M; Newman, F; Rabinovitch, R. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large b-cell lymphoma: a surveillance, epidemiology and end results (SEER) analysis. Int J Radiat Oncol Biol Phys 72(5): 1465-1471, 2008.
• McCammon, R; Schwer, A; Finlayson, C; Rabinovitch R. Survival impact of postmastectomy radiotherapy in T3N0 invasive ductal or lobular carcinoma of the breast: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Cancer 113(4): 683-689, 2008.
• Schwer, A; Ballonoff, A; McCammon, R; Rusthoven, K; Schefter, T. Survival impact of neoadjuvant radiotherapy prior to esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results (SEER) analysis. Int J Radiat Oncol Biol Phys 73(2): 449-455, 2009.
• Schwer, A; Kavanagh, B; McCammon, R; Gaspar, L; DeMasters, B; Stuhr, K; Chen, C. Radiographic and histopathologic observations after combined EGFR tyrosine kinase inhibition and hypofractionated stereotactic radiosurgery (SRS) in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 73(5): 1352-1357, 2009.
• Sperduto, P; Chao, S; Sneed, P; Luo, X; Suh, J; Roberge, D; Bhatt, A; Jensen, A; Brown, P; Shih, H; Kirkpatrick, J; Schwer, A; Gaspar, L; Fiveash, J; Chiang, V; Knisely, J; Sperduto, C; Mehta, M. Diagnosis-specific prognostic factors, indices and treatment outcomes for patients with new and recurrent brain metastases: a multi institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys 77(3): 655-661, 2010.
• Haider, Y; Bhatt, J; Ghavami, Y; Moshtaghi, O; Schwer, A; Chenery, S; Djalilian; H. Dosimetric analysis of neural and vascular structures in skull base tumors treated with stereotactic radiosurgery. Otolaryngol Head Neck Surg 156(5):857-862, 2017.
• Salgia, R; Mambetsariev, I; Tan, T; Schwer, A; Pearlstein, D; Chehabi, H; Baroz, A; Fricke, J; Pharaon, R; Romo, H; Waddington, T; Babikian, R; Buck, L; Kulkarni, P; Djulbegovic, B; Pal, S. Complex oncological decision-making utilizing fast-and-frugal trees in a community setting—role of academic and hybrid modeling. J Clin Med 9(6):1884, 2020.
• Liu, J; Ladbury, C; Waddington, T; Erhunmwunsee, L, Raz, D; Kim, J; Salgia, R; Schwer, A; Amini, A. Improved survival outcomes in medically fit patients with early-stage non-small-cell lung cancer undergoing stereotactic body radiation therapy. (Clin Lung Cancer. 2021 Sep;22(5):e678-e683. doi: 10.1016/j.cllc.2021.01.003. Epub 2021 Jan 19).

National Presentations/Published Abstracts

• Schwer, A. “Pancoast tumors”. The 4th Annual Rocky Mountain Region Thoracic Oncology Symposium, Denver, CO. Oral case presentation September 2006.
• Schwer, A; Borges, V; Ding, M and Kavanagh, B. The Norton-Simon hypothesis applied to murine and human tumor growth: implications for patient selection in stereotactic body radiation therapy (SBRT). ASTRO poster presentation October 2006. (Int J Radiat Oncol Biol Phys 66(3); S597, 2006.)
• Schwer, A; McCammon, R; Kavanagh, B; Gaspar, L; Damek, D; Chen, C. Magnetic resonance imaging (MRI) T1 and T2 volumetric changes and their implications after hypofractionated stereotactic radiotherapy (SRS) in Patients with Recurrent Malignant Gliomas. ASTRO poster discussion November 2007. (Int J Radiat Oncol Biol Phys 69(3); S167, 2007.)
• Ballonoff, A; McCammon, R; Schwer, A; Rusthoven, K; Rabinovitch, R. Improved survival in patients with stage I or II diffuse large B-cell lymphoma treated with radiotherapy: a surveillance, epidemiology and end results (SEER) analysis. ASTRO oral presentation November 2007. (Int J Radiat Oncol Biol Phys 69(3); S15-16, 2007.)
• Sperduto, P; Sneed, P; Bhatt, A; Schwer, A; Fiveash, J; Knisely, J; Zhu, Y; Sperduto, M; Gaspar L; Mehta, M. A multi-institutional validation study of a new prognostic index (Graded Prognostic Assessment) for patients with brain metastases. ASTRO oral presentation September 2008. (Int J Radiat Oncol Biol Phys 72(1); S51, 2008.)
• Altoos, T; Schwer, A; Modiano, J; Varella-Garcia, M; Iczkowski, KA; Franklin, W; Skokan, M; Helm, K; Sage-el, A; Schefter, TE. Temporal changes in PET SUV, tissue EGFR and CEC in neoadjuvant CRT for esophageal cancer. ASCO GI symposium poster presentation, January 2009.
• Sperduto, P; Chao, S; Sneed, P; Luo, X; Roberge, D; Bhatt, A; Jensen, A; Shih, H; Kirkpatrick, J; Schwer, A; Gaspar, L; Fiveash, J; Chiang, V; Knisely, J; Sperduto, C; Mehta, M. Diagnosis-specific prognostic factors, indices and treatment outcomes for patients with new and recurrent brain metastases: a multi-institutional analysis of over 5000 patients. ASTRO poster presentation, November 2009 (Int J Radiat Oncol Biol Phys 75(3); S225, 2009.)
• Sperduto, P; Xu, Z; Sneed, P; Luo, X; Roberge, A; Bhatt, A; Jensen, A; Shih, J; Kirkpatrick, J; Schwer, A; Gaspar, L. A graded prognostic assessment (GPA) for women with breast cancer and brain metastases. ASCO Annual Meeting Oral Presentation, June 2010 (J Clin Oncol 28(15s); 1028, 2010.)

Local/Regional/ Invited Presentations

• Keynote speaker at dozens of hospital grand rounds presentations, resident lecture series, patient support group lectures, nursing CME lectures, etc. (list available upon request)

Book Chapters

• Raben D, Schwer A, VanHoutte P. In: Pass HI, ed. Lung cancer: principles and practice, 4th ed. Baltimore: Williams and Wilkins, 2010.